Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.; Correction, 13931 [2020-04829]
Download as PDF
13931
Federal Register / Vol. 85, No. 47 / Tuesday, March 10, 2020 / Notices
Order
DEPARTMENT OF JUSTICE
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. FH4036667 issued to
William S. Husel, D.O. Further,
pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
823(f), I hereby deny any pending
application of William S. Husel to
renew or modify this registration, as
well as any other applications of
William S. Husel for an additional
registration in Ohio. This Order is
effective April 9, 2020.
Drug Enforcement Administration
Dated: January 29, 2020.
Uttam Dhillon,
Acting Administrator.
[FR Doc. 2020–04837 Filed 3–9–20; 8:45 am]
BILLING CODE 4410–09–P
[Docket No. DEA–592]
Importer of Controlled Substances
Application: Johnson Matthey Inc.
ACTION:
Notice of application.
Registered importers of the
affected basic classes, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration on or before April
9, 2020. Such persons may also file a
written request for a hearing on the
application on or before April 9, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
DATES:
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on September 11, 2019,
Johnson Matthey Inc., Pharmaceutical
Materials, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742
applied to be registered as an importer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Coca Leaves ....................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Opium, raw ......................................................................................................................................................................
Noroxymorophone ...........................................................................................................................................................
Poppy Straw Concentrate ...............................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to import Coca
Leaves (9040), Opium, raw (9600), and
Poppy Straw Concentrate (9670) in
order to bulk manufacture active
pharmaceutical ingredients (API) for
distribution to its customers. The
company plans to also import Thebaine
(9333), Noroxymorophone (9668), and
Fentanyl (9801) to use as analytical
reference standards, both internally and
to be sold to their customers to support
testing of Johnson Matthey Inc.’s active
pharmaceutical ingredients (API’s) only.
Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
November 22, 2019, concerning a notice
of application. As that document
correctly indicated, the applicant, S&B
Pharma, Inc., DBA Norac Pharma, 405
South Motor Avenue, Azusa, California
91702–3232 applied to be registered as
a bulk manufacturer of a number of
controlled substances, to include
applying for authorization in order to
synthetically manufacture using drug
code 7360 (marihuana). However, on the
notice of application published, drug
code 7360 was inadvertently identified
and listed as Gamma Hydroxybutyric
Acid instead of Marihuana.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2020–04836 Filed 3–9–20; 8:45 am]
Correction
BILLING CODE 4410–09–P
In the Federal Register of November
22, 2019, in FR Doc. 2019–25402 (84 FR
64563), on page 64564, correct the
listing of drug code 7360 to be identified
as Marihuana, as is shown below.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
khammond on DSKJM1Z7X2PROD with NOTICES
[Docket No. DEA–582]
Bulk Manufacturer of Controlled
Substances Application: S&B Pharma,
Inc.; Correction
Notice of application;
correction.
ACTION:
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register on
SUMMARY:
VerDate Sep<11>2014
17:20 Mar 09, 2020
Jkt 250001
Controlled substance
Drug
code
Schedule
Marihuana .................
7360
I
Dated: February 11, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–04829 Filed 3–9–20; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
9040
9333
9600
9668
9670
9801
Schedule
II
II
II
II
II
II
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–594]
Importer of Controlled Substances
Application: Arizona Department of
Corrections
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration on or before April
9, 2020. Such persons may also file a
written request for a hearing on the
application on or before April 9, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
DATES:
E:\FR\FM\10MRN1.SGM
10MRN1
Agencies
[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
[Notices]
[Page 13931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04829]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-582]
Bulk Manufacturer of Controlled Substances Application: S&B
Pharma, Inc.; Correction
ACTION: Notice of application; correction.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA) published a document
in the Federal Register on November 22, 2019, concerning a notice of
application. As that document correctly indicated, the applicant, S&B
Pharma, Inc., DBA Norac Pharma, 405 South Motor Avenue, Azusa,
California 91702-3232 applied to be registered as a bulk manufacturer
of a number of controlled substances, to include applying for
authorization in order to synthetically manufacture using drug code
7360 (marihuana). However, on the notice of application published, drug
code 7360 was inadvertently identified and listed as Gamma
Hydroxybutyric Acid instead of Marihuana.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of November 22, 2019, in FR Doc. 2019-25402
(84 FR 64563), on page 64564, correct the listing of drug code 7360 to
be identified as Marihuana, as is shown below.
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana............................ 7360 I
------------------------------------------------------------------------
Dated: February 11, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-04829 Filed 3-9-20; 8:45 am]
BILLING CODE 4410-09-P